BACKGROUND: Skin-sparing mastectomy, combined with immediate breast reconstruction, has become increasingly popular. However, there are no published long-term data to support its oncologic safety. Our purpose was to evaluate the long-term oncologic risk of skin-sparing mastectomy. METHODS: The records of all patients who had undergone treatment of T1 or T2 breast cancer by mastectomy and immediate breast reconstruction, and who were followed for at least 5 years or developed recurrence of disease before that time were reviewed. Local and distant recurrence rates observed in patients treated by skin-sparing mastectomy were compared with those in patients treated by conventional, non-skin-sparing mastectomy. RESULTS: A total of 104 patients were treated with skin-sparing mastectomies. In that group, 6.7% developed local recurrences, 12.5% developed distant metastases, 88.5% remained free of disease, and 7.7% died of their disease. Among the 27 patients who did not have skin-sparing mastectomies. 7.4% had local recurrences, 25.9% had distant metastases, 74.1% remained free of disease, and 18.5% died of disease. These recurrence rates are similar to those reported elsewhere after treatment with conventional mastectomy and without reconstruction. CONCLUSIONS: Our findings suggest that skin-sparing mastectomy does not significantly increase the risk of local or systemic disease recurrence in patients with early breast cancer.
BACKGROUND: Skin-sparing mastectomy, combined with immediate breast reconstruction, has become increasingly popular. However, there are no published long-term data to support its oncologic safety. Our purpose was to evaluate the long-term oncologic risk of skin-sparing mastectomy. METHODS: The records of all patients who had undergone treatment of T1 or T2 breast cancer by mastectomy and immediate breast reconstruction, and who were followed for at least 5 years or developed recurrence of disease before that time were reviewed. Local and distant recurrence rates observed in patients treated by skin-sparing mastectomy were compared with those in patients treated by conventional, non-skin-sparing mastectomy. RESULTS: A total of 104 patients were treated with skin-sparing mastectomies. In that group, 6.7% developed local recurrences, 12.5% developed distant metastases, 88.5% remained free of disease, and 7.7% died of their disease. Among the 27 patients who did not have skin-sparing mastectomies. 7.4% had local recurrences, 25.9% had distant metastases, 74.1% remained free of disease, and 18.5% died of disease. These recurrence rates are similar to those reported elsewhere after treatment with conventional mastectomy and without reconstruction. CONCLUSIONS: Our findings suggest that skin-sparing mastectomy does not significantly increase the risk of local or systemic disease recurrence in patients with early breast cancer.
Authors: Heriberto Medina-Franco; Luis O Vasconez; R Jobe Fix; Martin J Heslin; Samuel W Beenken; Kirby I Bland; Marshall M Urist Journal: Ann Surg Date: 2002-06 Impact factor: 12.969
Authors: Jamie L Wagner; Regina Fearmonti; Kelly K Hunt; Rosa F Hwang; Funda Meric-Bernstam; Henry M Kuerer; Isabelle Bedrosian; Melissa A Crosby; Donald P Baumann; Merrick I Ross; Barry W Feig; Savitri Krishnamurthy; Mike Hernandez; Gildy V Babiera Journal: Ann Surg Oncol Date: 2011-10-07 Impact factor: 5.344
Authors: Monica G Valero; Shirin Muhsen; Tracy-Ann Moo; Emily C Zabor; Michelle Stempel; Andrea Pusic; Mary L Gemignani; Monica Morrow; Virgilio S Sacchini Journal: Ann Surg Oncol Date: 2019-12-10 Impact factor: 5.344
Authors: Miguel De La Parra Marquez; Ricardo Fernandez-Riera; Hector Vela Cardona; Jesus María Rangel Flores Journal: World J Surg Oncol Date: 2018-04-17 Impact factor: 2.754